Page 1 | Search Results | Blood | American Society of Hematology

1-16 of 16

Sort by

Sort Order Select

Journal Articles

Allogeneic Hematopoietic Stem Cell Transplant in Children with Relapsed/Refractory Acute Lymphoblastic Leukemia: Ambulatory or in-Hospital?

Guillermo José Ruiz-Argüelles, Olivia Lira-Lara, Max Robles-Nasta, Juan Carlos Olivares-Gazca, Moisés Manuel Gallardo-Pérez, Edgar Jared Hernández-Flores, David Gomez-Almaguer, Oscar Gonzalez Llano, Yajaira Valentina Jimenez-Antolinez, Guillermo José Ruiz-Delgado

Blood (2024) 144 (Supplement 1): 7427.

https://doi.org/10.1182/blood-2024-199795

Published: 2024

Journal Articles

Pembrolizumab in Children, Adolescents, and Young Adults with Low-Risk Classic Hodgkin Lymphoma (cHL) and Slow Early Response to Front-Line Chemotherapy: Updated Results from the Phase 2 Keynote-667 Study

Blood (2024) 144 (Supplement 1): 462.

https://doi.org/10.1182/blood-2024-199263

Published: 2024

Journal Articles

Exploring the Efficacy and Feasibility of Outpatient Blinatumomab Short Cycles in Pediatric Patients with Relapsed/Refractory B-ALL in LMIC: Preliminary Results

Julia Esther Colunga Pedraza, Samantha Rodriguez, Ingrid López-Reyna, Lucía Hernández Torres, Perla Rocio Colunga Pedraza, Valeria Fuentes, David Gomez-Almaguer, Yajaira Valentina Jimenez-Antolinez, Oscar Gonzalez Llano

Blood (2023) 142 (Supplement 1): 5813.

https://doi.org/10.1182/blood-2023-190271

Published: 2023

Journal Articles

Pembrolizumab (pembro) in Children and Young Adults with Low-Risk Classical Hodgkin Lymphoma (cHL) with Slow Early Response (SER) to Front-Line Chemotherapy (chemo): Early Results from the Phase 2 Keynote-667 Study

Blood (2023) 142 (Supplement 1): 1700.

https://doi.org/10.1182/blood-2023-186719

Published: 2023

Journal Articles

Capizzi Vs HDMTX in the Intermediate Maintenance Phase in Patients with Intermediate-Risk ALL in a 3rd Level Hospital in Northeastern Mexico

Valeria Fuentes, Yajaira Valentina Jimenez-Antolinez, Ginna Mariana Romero-Jacobo, Paulina Garcia - Maldonado, Juan Pablo Ruiz-Padilla, Samantha Carolina Rodriguez- Miranda, Jorge Federico Marcos-Garcia, Julia Esther Colunga Pedraza, David Gomez-Almaguer, Oscar Gonzalez Llano

Blood (2023) 142 (Supplement 1): 5883.

https://doi.org/10.1182/blood-2023-190990

Published: 2023

Journal Articles

CRLF2 Expression in Mexicans with Acute Lymphoblastic Leukemia across the Age Spectrum

Héctor A. Martínez-Espinosa, Nereida Méndez-Ramírez, Julia Colunga Pedraza, Eli Fuentes-Chávez, Rosario Salazar-Riojas, Odra L. Martínez-González, Antonio Vega-Mateos, Oscar Gonzalez Llano, Ingrid López-Reyna, David Gomez-Almaguer, Andres Gomez-De Leon, Vanessa Treviño-Sordia, Roberto Solano-Texta

Blood (2023) 142 (Supplement 1): 6054.

https://doi.org/10.1182/blood-2023-188339

Published: 2023

Journal Articles

Outpatient Transplantation during the COVID19 Pandemic: Stretching the Limits for Continuing Care

Perla R. Colunga Pedraza, MD, Julia Esther Colunga Pedraza, MD, Andres Gomez-De Leon, MD, Mónica Bustillos Muñoz, MD, Karen Lorena Osorno-Rodriguez, MD, Jose Angel Hawing, MD, Oscar Gonzalez Llano, MD, Yajaira Valentine Jimenez-Antolinez, MD, Olga Graciela Cantu Rodriguez, MD, Cesar Homero Gutierrez-Aguirre, PhD, David Gomez-Almaguer, MD

Blood (2020) 136 (Supplement 1): 31.

https://doi.org/10.1182/blood-2020-142035

Published: 2020

Journal Articles

Changing the Fate of Children with Acute Lymphoblastic Leukemia (ALL) in a Limited Resources Setting

Yajaira Valentine Jimenez-Antolinez, MD, Julia Esther Colunga Pedraza, MD, José Eduardo Mares-Gil, MD, Emma Lizeth Estrada, MD, Jesus Mauricio Gonzalez-Diaz, David Gomez-Almaguer, MD, Oscar Gonzalez Llano, MD

Blood (2019) 134 (Supplement_1): 5075.

https://doi.org/10.1182/blood-2019-132205

Published: 2019

Journal Articles

Moral Distress, Anxiety, and Others Physical Symptoms Related to Hematopoietic Stem Cell Donation

Cesar Homero Gutierrez-Aguirre, PhD, Olga Graciela Cantu Rodriguez, MD, Fernando De la Garza-Salazar, MD, Rosario Salazar Riojas, Chem., Andres Gomez De Leon, MD, Perla R. Colunga Pedraza, MD, Geraldina Guerrero-González, PhD, Jose Carlos Jaime, MD PhD, Guillermo J. Ruiz-Arguelles, FRCP, MACP, David Gomez-Almaguer, MD, Oscar Gonzalez Llano, MD, Consuelo Mancias, MD

Blood (2019) 134 (Supplement_1): 1967.

https://doi.org/10.1182/blood-2019-131791

Published: 2019

Journal Articles

Outpatient Haploidentical Stem Cell Transplantation Using Post-Transplant Cyclophosphamide Is Feasible. Experience in a Single Latin-American Center

Perla Rocio Colunga Pedraza, MD, Andres Gomez De Leon, MD, Guillermo Sotomayor Duque, MD, Julia Esther Colunga Pedraza, MD, Yadith Karina López García, Paola Santana-Hernandez, Cesar Homero Gutierrez Aguirre, Olga Cantu Rodriguez, MD, Luz del Carmen Tarín Arzaga, MD, Oscar Gonzalez Llano, MD, David Gomez-Almaguer, MD

Blood (2017) 130 (Supplement 1): 1940.

https://doi.org/10.1182/blood.V130.Suppl_1.1940.1940

Published: 2017

Journal Articles

Outpatient Haploidentical Peripheral Blood Stem-Cell Transplantation with Post-Transplant Cyclophosphamide in Children and Adolescents

Oscar Gonzalez-Llano, MD PhD, Elias Eugenio Gonzalez-Lopez, MD, Ana Carolina Ramirez-Cazares, MD, Edson Rene Marcos-Ramirez, MD, Guillermo J. Ruiz-Arguelles, MD FRCP (Glasg), MACP, David Gomez-Almaguer, MD

Blood (2015) 126 (23): 4389.

https://doi.org/10.1182/blood.V126.23.4389.4389

Published: 2015

Journal Articles

Low Dose Rituximab and Plasma Exchange As Frontline Therapy for Patients with Thrombotic Thrombocytopenic Purpura

Alberto Vazquez Mellado, MD, Olga Graciela Cantu-Rodriguez, MD, Myrna Pequeño-Luévano, MD, Laura Villarreal-Martínez, MD, José Carlos Jaime-Pérez, MD, Andres Gomez-De-Leon, MD, Oscar Gonzalez-Llano, MD PhD, Perla Colunga-Pedraza, MD, Guillermo Sotomayor-Duque, David Gomez-Almaguer, MD

Blood (2015) 126 (23): 2257.

https://doi.org/10.1182/blood.V126.23.2257.2257

Published: 2015

Journal Articles

Autologus Hematopoietic Stem Cell Transplant in Type 1 Diabetes Mellitus in a Nonmyeloablative and Outpatient Setting

Olga Graciela Cantú-Rodríguez, MD, Fernando Lavalle-Gonzalez, MD, Miguel Angel Herrera-Rojas, MD, Cesar H Gutiérrez-Aguirre, MD, Consuelo Mancías-Guerra, MD, Jose Carlos Jaime-Pérez, MD, Oscar Gonzalez-Llano, MD, Alfonso Zapata-Garrido, MD, Jesus Zacarias Villarreal-Perez, MD, David Gomez-Almaguer, MD

Blood (2014) 124 (21): 1191.

https://doi.org/10.1182/blood.V124.21.1191.1191

Published: 2014

Journal Articles

Low Incidence and severity of Graft-Versus-host disease after outpatient allogeneic Peripheral Blood Stem Cell Transplantation employing a Reduced-Intensity Conditioning

Olga Cantú-Rodríguez, MD, Juan A. Flores-Jiménez, MD, Cesar H Gutiérrez-Aguirre, MD, Guillermo J. Ruiz-Arguelles, MD, FACP, FRCP, (Glasg), A López-Otero, MD, Consuelo Mancías-Guerra, MD, Oscar Gonzalez-Llano, MD, Oscar Treviño-Montemayor, Jose C. Jaime-Pérez, MD, Silvia Martínez-Cabriales, David Gomez-Almaguer, MD

Blood (2011) 118 (21): 4707.

https://doi.org/10.1182/blood.V118.21.4707.4707

Published: 2011

Journal Articles

Subcutaneous Alemtuzumab May Be Useful in the Treatment of Steroid-Refractory Acute Graft- Versus -Host Disease.

David Gomez-Almaguer, MD, Guillermo J. Ruiz-Arguelles, MD, FACP, FRCP, Oscar Gonzalez-Llano, MD, Homero C. Gutierrez-Aguire, MD, Olga G. Cantu-Rodriguez, MD, Jose C. Jaime-Perez, MD, Sergio Giralt, MD

Blood (2007) 110 (11): 2983.

https://doi.org/10.1182/blood.V110.11.2983.2983

Published: 2007

Journal Articles

Alemtuzumab in the Treatment of Steroid Refractory Acute Graft-Versus-Host Disease.

David Gomez-Almaguer, Guillermo Ruiz-Arguelles, Oscar Gonzalez-Llano, Olga G. Cantu, Cesar H. Gutierrez, Jose Carlos Jaime-Perez, Luz Tarin-Arzaga, Sergio Giralt

Blood (2006) 108 (11): 5294.

https://doi.org/10.1182/blood.V108.11.5294.5294

Published: 2006

NARROW

Allogeneic Hematopoietic Stem Cell Transplant in Children with Relapsed/Refractory Acute Lymphoblastic Leukemia: Ambulatory or in-Hospital?

Pembrolizumab in Children, Adolescents, and Young Adults with Low-Risk Classic Hodgkin Lymphoma (cHL) and Slow Early Response to Front-Line Chemotherapy: Updated Results from the Phase 2 Keynote-667 Study

Exploring the Efficacy and Feasibility of Outpatient Blinatumomab Short Cycles in Pediatric Patients with Relapsed/Refractory B-ALL in LMIC: Preliminary Results

Pembrolizumab (pembro) in Children and Young Adults with Low-Risk Classical Hodgkin Lymphoma (cHL) with Slow Early Response (SER) to Front-Line Chemotherapy (chemo): Early Results from the Phase 2 Keynote-667 Study

Capizzi Vs HDMTX in the Intermediate Maintenance Phase in Patients with Intermediate-Risk ALL in a 3rd Level Hospital in Northeastern Mexico

CRLF2 Expression in Mexicans with Acute Lymphoblastic Leukemia across the Age Spectrum

Outpatient Transplantation during the COVID19 Pandemic: Stretching the Limits for Continuing Care

Changing the Fate of Children with Acute Lymphoblastic Leukemia (ALL) in a Limited Resources Setting

Moral Distress, Anxiety, and Others Physical Symptoms Related to Hematopoietic Stem Cell Donation

Outpatient Haploidentical Stem Cell Transplantation Using Post-Transplant Cyclophosphamide Is Feasible. Experience in a Single Latin-American Center

Outpatient Haploidentical Peripheral Blood Stem-Cell Transplantation with Post-Transplant Cyclophosphamide in Children and Adolescents

Low Dose Rituximab and Plasma Exchange As Frontline Therapy for Patients with Thrombotic Thrombocytopenic Purpura

Autologus Hematopoietic Stem Cell Transplant in Type 1 Diabetes Mellitus in a Nonmyeloablative and Outpatient Setting

Low Incidence and severity of Graft-Versus-host disease after outpatient allogeneic Peripheral Blood Stem Cell Transplantation employing a Reduced-Intensity Conditioning

Subcutaneous Alemtuzumab May Be Useful in the Treatment of Steroid-Refractory Acute Graft- Versus -Host Disease.

Alemtuzumab in the Treatment of Steroid Refractory Acute Graft-Versus-Host Disease.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only